🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Percutaneous Intercostal Cryoneuromodulation Onset Timing.

Recruitingn/aAges 12 Years - 40 YearsAllPapa Giovanni XXIII Hospital
NCT07081620 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Percutaneous Intercostal Cryoneurolysis is a promising technique that addresses acute postoperative pain after Nuss procedure for pectus excavatum. However its onset timing has not yet been determined. A physical examination would assess the variation of chest skin sensitivity to soft touch, cold (water at 4°C), and heat (water at 40°C) through days following the cryoneurolysis procedure.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients who are undergoing preoperative percutaneous intercostal cryoneurolysis for pectus excavatum surgery Exclusion Criteria: * failure to obtain consent
💊

What it tests

  • Physical examination of chest skin
📍

Where

1 site
Papa Giovanni XXIII Hospital
Bergamo, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy